The market reaction came as Trump signed a wide-ranging executive order aimed at slashing prescription drug prices in the US.

UnitedHealth Group earlier Tuesday suspended its earnings guidance for 2025, prompting investors to pull back on shares of the company and other names in the healthcare space.

CVS Health Corporation CVS and The Cigna Group CI shares trading lower Tuesday. President Donald Trump on Monday signed an executive order aimed at reducing the cost of prescripti ...

Witty will act as a senior advisor to his successor, Stephen Hemsley, who served as UnitedHealth Group's CEO from 2006 to ...

The blow came from the highest levels of government, spooking investors and driving down the stock prices of numerous ...

UnitedHealth Group shares plunged in premarket trading as the firm announced a surprise exit of the current CEO and pulled its full-year forecast.

Key Takeaways The S&P 500 rose 3.3% on Monday, May 12, 2025, as investors reviewed a trade deal between the U.S. and China ...

Eli Lilly Downplays CVS Move to Drop Zepbound Coverage, Shares Plunge By Bhanvi Satija ... U.S. PBMs - UnitedHealth Group's OptumRx and Cigna's Express Scripts - did not respond to queries about ...

Cigna shares have added about 21.4% since the beginning of the year versus the S&P 500's decline of -4.7%. While Cigna has outperformed the market so far this year, the question that comes to ...

(Reuters) -Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of medicines it covers for reimbursement, but shares of the drugmaker ...